3Krauss RM. Triglycerides and Atherogenic Lipoproteins: Rationale for lipid management[J]. Am J Med, 1998,105(IA) : 588-597.
4Xu N,Dahlback B, Ohlin AK, et al. Association of vitamin K-dependent coagulation protein and C4b binding protein with triglyceride-rich. lipoproteins of human plasma[J]. Arterioseler Tromb Vase Biol, 1998,18(l) :33-39.
5Grundy SM, Small LDL. Atherogenic dyslipidemia and the metablic syndrome[J]. Circulation. 1997.95 (1) : 1-4.
6Hopfner RL, McNeill JR, Gopalakrishnan V. Plasma endothelin levels and vascular responses at different temporal stages of streptozotocin diabetes[J]. Eur J Pharmaeol, 1999,374(2) :221-227.
7Webb ML, Meek TD. Inhibitors of endothdin [J]. Med Res Rev, 1997,17(1) :17-67.
8Faraci FM,Heistad DD. Regulation of the cerebral circulation: role of endothelium and potassium channels [J]. Physiol Rev, 1998,78(1) : 53-97.
9Messmer UK, Lapetina EG, Brune B. Nitric Oxide-mediated apoptosis in raw 264.7 macrophages is antagonized by protein kinase C-and protein kinase A-activating compounds[J]. Mol Phmmacol, 1995,47 (4) :757-765.
10Albina JE,Cui $, Mateo RB, et al. Nitric oxlde-mediated apoptosis in murlne peritoneal, macrophages [J]. J Immonul, 1993,150(11) : 5080-5085.
2[1]Todd J.System nature of endothelial dysfunction in atherosclerosis.Am J Cardiol,1995,75:71B
3[2]Vogel RA,Corretti MC,Plotnick GD.Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men.Am J Cardiol,1996,77:37～40
4[3]Kool M,Lusstermans F,Kragten H,et al.Does lowering of cholesterol levels influence functional properties of large arteries?Eur J Clin Pharmacol,1995,48:217～223
5[4]Celermajer DS,Sorensen K,Gooch VM,Ryalls M,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.Lancet,1992,340:1111～1115
6[5]Ludmer PL,Selwyn AP,Shook TL,et al.Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries.N Engl J Med,1986,315:1046～1051
7[6]Anderson TJ,Uehata A,Gerhard MD,et al.Close relation of endothelial function in the human coronary and peripheral circulations.J Am Coll Cardiol,1995,26:1235～1241
4KIM S Y, SONG H J, LEE Y Y, et al. Biomedical Issues of Dietary fiber -Glucan [J]. Korean Med Sci, 2006,21(3) : 781- 789.
5PAUL M, VANHOUTTE M D. Endothelial Dysfunction :The first step toward coronary arteriosclerosis [ J ]. Circ J, 2009,73 (6) : 595-601.
6SAGACH V, BONDARENKO A, BAZILYUK O, et al. Endothelial dysfunction: Possible mechanisms and ways of correction [ J ]. Exp Clin Cardiol, 2006,11 ( 2 ) : 107-110.
7HADI H A, CARR C S, SUWAIDI J. Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome [ J ]. Vasc Health Risk Manag, 2005,1 ( 3 ) : 183-198.
8PECHANOVA O, SIMKO F. The role of nitric oxide in the maintenance of vasoaetive balance [ J ]. Physiol Res, 2007,56 (2) :S7-S16.
9HANSSON G K. Inflammation, atherosclerosis and coronary artery disease [ J]. N Engl J Med, 2005, 352 (16) : 1685-1695.
